Science Explorer Back to mapMap
Discussion
Researcher · Toho University · Japan

Go Sano

Go Sano publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Epidemiology, on topics such as Lung Cancer Treatments and Mutations, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Cancer Genomics and Diagnostics.

OpenAlex
World rank
#3,843,918
of 7,710,434 ranked researchers
Rank in Japan
#100,152
of 383,136
Works
64
Citations
845
Citations per work
13.2
h-index
12
i10-index 20Top 42% in Pulmonary and Respiratory Medicine
Go Sano

What does Go Sano research?

Go Sano's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (5%).

Health Sciences: 44 works · 68.3% of their workMedicine: 44 works · 68.3% of their workPulmonary and Respiratory Medicine: 25 works · 38.3% of their workOncology: 6 works · 10.0% of their workEpidemiology: 6 works · 8.9% of their workSurgery: 4 works · 6.1% of their workInfectious Diseases: 3 works · 5.0% of their workEverything else: 17 works · 26.7% of their workLife Sciences: 3 works · 5.0% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 5.0% of their workCancer Research: 3 works · 5.0% of their workTHEIR WORKGo Sano64works
Life Sciences5%Health Sciences68%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4468.3%
  2. Everything else1726.7%
    1. Biochemistry, Genetics and Molecular Biology35.0%
  1. 1Pulmonary and Respiratory Medicine38% of their works
  2. 2Oncology10% of their works
  3. 3Epidemiology9% of their works
  4. 4Surgery6% of their works
  5. 5Cancer Research5% of their works
  6. 6Infectious Diseases5% of their works

Research topics

Which keywords describe Go Sano's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Epithelial-Mesenchymal Transition, ALK Inhibitors, EGFR Mutations, Fibrosis, Idiopathic Pulmonary Fibrosis and Chemotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Targeted Therapy323 topics
  2. Clinical Trials252 topics
  3. Epithelial-Mesenchymal Transition252 topics
  4. ALK Inhibitors201 topic
  5. EGFR Mutations201 topic
  6. Fibrosis201 topic
  7. Idiopathic Pulmonary Fibrosis201 topic
  8. Chemotherapy122 topics
  9. Diagnosis92 topics
  10. CT Screening71 topic
  11. Cancer Genomics71 topic
  12. Lung Cancer71 topic
  13. Mutational Signatures71 topic
  14. COPD51 topic
  15. Cancer Stem Cells51 topic
  16. Genomic Profiles51 topic
  17. Small-Cell Lung Cancer51 topic
  18. Tumor Metastasis51 topic
  19. spirometry51 topic
  20. Mycobacterium avium41 topic
  21. Nontuberculous Mycobacteria41 topic

Where does Go Sano work?

Go Sano's main affiliation in the publication record is Toho University, Japan.

How many publications and citations does Go Sano have?

OpenAlex counts 64 works and 845 citations for Go Sano, an h-index of 12, ranking #3,843,918 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Go Sano. Posts are plain text and can be reported.